• Exchange: Tel Aviv
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharma

Redhill Biopharma Ltd

+ Add to Watchlist

RDHL:IT

464.00 ILs 28.60 6.57%

As of 06:22:36 ET on 12/18/2014.

Snapshot for Redhill Biopharma Ltd (RDHL)

Open: 446.00 Day's Range: 443.80 - 464.00 Volume: 70,575
Previous Close: 435.40 52wk Range: 295.00 - 680.00 1-Yr Rtn: +40.42%

Stock Chart for RDHL

No chart data available.
  • RDHL:IT 484.90
  • 1D
  • 1M
  • 1Y
435.40
Interactive RDHL Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for RDHL

Current P/E Ratio (ttm) -
Estimated P/E(12/2014) -
Relative P/E vs. TA-100 -
Earnings Per Share (USD) (ttm) -0.1111
Est. EPS (USD) (12/2014) -1.3900
Est. PEG Ratio -
Market Cap (M ILS) 401.54
Shares Outstanding (M) 87.88
30 Day Average Volume 175,730
Price/Book (mrq) 3.6131
Price/Sale (ttm) 14.6582
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 02/17/2015
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for RDHL

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for RDHL

Redhill Biopharma Ltd focuses primarily on the development and acquisition of therapeutic candidates acquired through asset purchases or in-licensing. The Company acquires, in-licenses and develops patent-protected new formulations and combinations of existing drugs in advanced stages of development.

Dror Ben-AsherChairman/CEOOri ShiloDpty CEO:Finance & Operations
Uri Hananel AharonChief Accounting OfficerGuy GoldbergChief Business Officer
More Company Profile & Key Executives for RDHL

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil